Peregrine Asset Advisers’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-3,000
| Closed | -$279K | – | 106 |
|
2017
Q3 | $279K | Hold |
3,000
| – | – | 0.15% | 67 |
|
2017
Q2 | $272K | Hold |
3,000
| – | – | 0.17% | 66 |
|
2017
Q1 | $263K | Hold |
3,000
| – | – | 0.14% | 70 |
|
2016
Q4 | $249K | Hold |
3,000
| – | – | 0.15% | 88 |
|
2016
Q3 | $278K | Buy |
+3,000
| New | +$278K | 0.17% | 84 |
|